Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Community Pharmacy
100%
Cross-Sectional Study
98%
Prevalence
80%
Polypharmacy
60%
Congestive Heart Failure
40%
Thromboembolism
40%
Thymocyte Antibody
40%
Avatrombopag
40%
Classical Hodgkin Lymphoma
40%
Nivolumab
40%
Immunosuppressive Agent
40%
Tacrolimus
33%
Drug Interaction
25%
Drug Information
20%
Pharmacy Management
20%
Glucagon Like Peptide 1 Receptor Agonist
20%
Adverse Drug Reaction
20%
Hyperkalemia
20%
Albuminuria
20%
Pharmacovigilance
20%
FDA Adverse Event Reporting System
20%
Leporidae
15%
Mycophenolate Mofetil
13%
Prednisone
13%
Methylprednisolone
13%
Acute Graft Rejection
13%
Infectious Complication
10%
Pharmacokinetic Modeling
10%
Biological Marker
10%
Drug Dispensing
10%
Adverse Event
9%
Diabetes Mellitus
8%
Clinical Pharmacy
8%
Chronic Liver Disease
8%
Overall Survival
5%
Rash
5%
Incretin
5%
Graft Dysfunction
5%
Prospective Study
5%
Infection Rate
5%
Clinical Trial
5%
Tubular Dysfunction
5%
Pathophysiology
5%
Heart Arrhythmia
5%
Progression Free Survival
5%
Brentuximab Vedotin
5%
Programmed Death 1 Receptor
5%
Hodgkin Disease
5%
Infusion Related Reaction
5%
Medicine and Dentistry
Kidney Graft
80%
Prevalence
44%
Nivolumab
40%
Classical Hodgkin Lymphoma
40%
Homeopathy
40%
Thymocyte Antibody
40%
Liver Graft
40%
Avatrombopag
40%
Thromboembolism
40%
Retrospective Study
40%
Diabetes Mellitus
40%
Awareness
40%
Community Pharmacy
40%
Cross Sectional Study
33%
Student T Test
24%
Patient Health Questionnaire 9
22%
Glucagon-Like Peptide-1 Agonist
20%
Systematic Review
20%
Counseling
20%
Hyperkalemia
20%
Primary Health Care
20%
Patient Counseling
20%
Albuminuria
20%
Drug Interaction
18%
Immunosuppressive Treatment
18%
Immunosuppressive Drug
17%
Tacrolimus
14%
Kidney Transplantation
14%
Health Care Personnel
13%
Progression Free Survival
10%
Prednisone
10%
Acute Graft Rejection
10%
Methylprednisolone
10%
Immunosenescence
10%
Mycophenolate Mofetil
10%
Infectious Complication
10%
Drug Exposure
10%
Biological Marker
10%
Clinical Trial
9%
Diabetes
8%
Contraindication
8%
Thrombocytopoiesis
8%
T Cell
7%
Angiotensin Receptor Antagonist
6%
Infusion Related Reaction
5%
Autologous Stem Cell Transplantation
5%
Programmed Death 1 Receptor
5%
Immunosurveillance
5%
Brentuximab Vedotin
5%
Infection Rate
5%
Nursing and Health Professions
Prevalence
80%
Community Pharmacist
66%
Cross-Sectional Study
63%
Immunosuppressive Treatment
53%
Care (Medicine)
40%
Self Care
40%
Liver Graft
40%
Homeopathy
40%
Patient with Type 2 Diabetes
40%
Hospital Department
40%
Kidney Graft
40%
Congestive Heart Failure
20%
Patient Health Questionnaire 9
20%
Polypharmacy
20%
Mycophenolate Mofetil
20%
Tertiary Care Center
20%
Medication Therapy Management Service
20%
Saudi Arabia
20%
Hypertension
20%
Immunosuppressive Agent
17%
Odds Ratio
16%
Diabetes Mellitus
16%
Primary Health Care
13%
Health Care Personnel
13%
Counseling
10%
Patient Counseling
10%
Acute Graft Rejection
10%
Tacrolimus
10%
Student T Test
10%
Chronic Kidney Failure
10%
Adherence
8%
Confidence Interval
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Albumin
6%
Practice Guideline
6%
Creatinine
6%
Cross-Sectional Survey
5%
Patient Health Questionnaire
5%
Prednisone
5%
Methylprednisolone
5%
Maturity Onset Diabetes of the Young
5%
